Downstream Processing Market Will Hit $51.0 Billion Value by 2030

By 2030, the worldwide downstream processing market is predicted to hit a $51.0 billion, growing from $21.1 billion in 2021 at a 10.3% compound annual growth rate between 2021 and 2030. This is owing to the expanding biotechnology sector, growing significance of contract manufacturing organizations, and burgeoning R&D investment in the biopharmaceutical industry.

Get the sample pages of this report: https://www.psmarketresearch.com/market-analysis/downstream-processing-market/report-sample

Biopharmaceutical is one of the industries with the highest potential for growth in the future. In the coming years, this industry is expected to rank among the top 10 revenue sources, according to several healthcare organizations. Therefore, businesses are working to strengthen their presence in this downstream processing market, to meet the growing demand for bio-based medications, which increases the accessibility of bio-drugs for clinical usage.

High-resolution membrane systems have been widely used as a result of the rise in the R&D activities related to perfusion chromatography systems, high-throughput process development, improved bioprocess technologies, and continuous downstream processing systems for multicomponent separations.

The category of antibody production is expected to grow at a CAGR of about 10.9% till 2030, due to the growing requirement for monoclonal antibodies (mAb). This class of new-age molecules are used for pregnancy and diagnostic testing, cancer detection and immunotherapy, and viral disease treatment.

Based on product type, the chromatography systems category dominates the downstream processing market with a 37.5% revenue share. The development of the market is expected to be influenced by the continuous R&D aimed at improving the speed and efficiency of chromatography systems.

Inquire before purchase@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=downstream-processing-market

The category of solid-liquid separation is expected to see the fastest advance in the coming years owing to this technique's simplicity, cost-effectiveness, and better suitability for continuous-mode production.

Moreover, purification by chromatography holds the majority share of the market. To meet the regulatory standards, there is a strong need for ultra-pure biopharmaceutical products. As downstream purification is essential for enhancing product quality and purity, the demand for this purification method continues to grow.

About P&S Intelligence

P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.

Contact:
P&S Intelligence
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.